Arteris (NASDAQ:AIP) COO Sells $296,799.51 in Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 12,219 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $24.29, for a total value of $296,799.51. Following the sale, the chief operating officer directly owned 194,659 shares of the company’s stock, valued at $4,728,267.11. This represents a 5.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Stock Down 2.4%

AIP stock opened at $22.84 on Friday. The firm has a market capitalization of $1.12 billion, a PE ratio of -26.25 and a beta of 1.90. The stock’s 50 day moving average is $24.44 and its 200-day moving average is $28.78. Arteris, Inc. has a twelve month low of $12.06 and a twelve month high of $50.26. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. Sell-side analysts expect that Arteris, Inc. will post -0.68 EPS for the current fiscal year.

Institutional Investors Weigh In On Arteris

A number of hedge funds and other institutional investors have recently bought and sold shares of AIP. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Arteris in the second quarter valued at $53,000. Versant Capital Management Inc boosted its stake in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after purchasing an additional 290 shares during the period. Farther Finance Advisors LLC grew its holdings in Arteris by 106.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock valued at $41,000 after buying an additional 890 shares in the last quarter. Allworth Financial LP bought a new stake in shares of Arteris during the second quarter valued at about $87,000. Finally, State of Wyoming purchased a new stake in shares of Arteris in the second quarter worth about $165,000. Institutional investors own 64.36% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on AIP shares. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and increased their price target for the company from $35.00 to $50.00 in a research report on Friday, August 7th. Roth Capital started coverage on Arteris in a research note on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price objective for the company. Oppenheimer assumed coverage on Arteris in a research report on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price for the company. Rosenblatt Securities reissued a “buy” rating and issued a $38.00 price target on shares of Arteris in a report on Friday, August 7th. Finally, Craig Hallum started coverage on shares of Arteris in a research report on Monday, September 21st. They set a “buy” rating and a $30.00 price target for the company. Six research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Arteris currently has a consensus rating of “Moderate Buy” and an average target price of $39.43.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris received an additional $3.3 million from the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The funding supports Arteris’ role in securing hardware-design supply chains and may improve its positioning in government and advanced-chip projects. Arteris funding article
• Positive Sentiment: The funding has renewed the “undervalued” investment narrative around Arteris, with investors focusing on potential long-term demand for semiconductor security and the company’s strategic partnerships. Oppenheimer also maintained its Buy rating, reinforcing the constructive analyst view. Arteris undervalued narrative article Oppenheimer rating article
• Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple share sales. Several transactions were associated with tax-withholding obligations when equity awards vested, which limits their value as a signal of weakening management confidence. Laurent Moll insider sale
• Negative Sentiment: Bayview Legacy LLC sold 100,000 shares, worth approximately $2.38 million. Unlike the executive transactions, the filing did not identify tax withholding as the reason, potentially adding selling pressure and investor caution, although the holder still retains a sizable position. Bayview Legacy insider sale
• Negative Sentiment: Arteris’ latest quarterly EPS loss was wider than analysts expected, and the company remains unprofitable. That fundamental backdrop may be offsetting optimism about the new funding and analyst support.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.